Skip to main content

Table 2 Averaged antimicrobial resistance of the main Gram negative uropathogens for female and male patients

From: Frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections: a ten-year surveillance study (2000–2009)

Antimicrobial group

Antimicrobials

E. coli

P. mirabilis

Klebsiella spp

P. vulgaris

P. aeruginosa

Enterobacter spp

Providencia spp

  

N

%

M

F

N

%

M

F

N

%

M

F

N

%

M

F

N

%

M

F

N

%

M

F

N

%

M

F

Aminoglycosides

Amikacin

12048

1.5

1.9

1.4

865

4.3

5.7

3.8

800

2.6

2.6

2.6

492

7.3

6.4

7.6

443

7.9

7.1

8.7

360

7.8

9.1

7.0

307

92.8

89.2

93.8

Gentamicin

12034

3.6

6.3*

3.1

868

5.4

7.1*

4.9

798

7.3

8.4

6.8

487

12.9

12.2

13.2

441

15.2

15.7

14.7

361

10.8

13

9.6

307

93.8

90.8

94.6

Isepamicin

10995

1.3

1.8

1.3

787

3.4

4.6

3.1

707

2.0

2.4

1.8

444

6.3

5.4

6.6

387

8.3

8.2

8.3

348

3.2

4.1

2.7

282

92.9

91.7

93.2

Netilmicin

11976

1.3

1.7

1.2

854

0.9

2.9*

0.3

792

2.5

2.7

2.5

484

5.8

7.3

5.3

443

14.4

15.6

13.4

358

8.7

14.5*

5.3

307

94.5

93.8

94.6

Tobramycin

11999

3.0

4.9*

2.6

860

4.1

7.3*

3.1

793

5.8

8.0*

4.9

494

12.6

14.4

11.9

443

16.5

17.0

16.0

358

14.5

23.1*

9.6

306

94.4

93.8

94.6

Carbapenems

Imipenem

11846

0.2

0.4

0.1

846

1.3

2.9*

0.8

785

0.4

0.0

0.5

482

2.9

2.4

3.1

425

2.4

2.0

2.7

337

2.1

4.3*

0.9

308

1.3

3.2

0.8

Cephalosporins 1st G

Cefazolin

11919

10.5

15.8*

9.4

862

22.2

31.1*

19.3

766

29.9

37.3*

26.9

484

94.8

97.6

93.8

152

98.0

97.3

98.7

346

96.0

97.6

95.0

311

95.5

92.4

96.3

Cephradine

11994

14.1

19.2*

13.0

862

22.3

30.8*

19.5

788

32.0

38.1

29.6

486

95.9

98.4

95.0

155

98.7

98.7

98.8

360

96.4

97.7

95.6

310

96.8

95.3

97.2

Cephalosporins 2nd G

Cefoxitin

11954

5.1

7.2*

4.7

860

15.8

20.2*

14.4

781

19.0

23.1

17.3

489

26.8

33.9

24.4

170

97.6

98.8

96.6

353

64.0

74.6*

58.1

308

8.4

19.0*

5.7

Cefuroxime

11933

4.3

6.7*

3.8

863

9.6

12.9*

8.6

781

16.1

22.0*

13.8

481

25.4

32.5*

22.9

165

98.8

98.8

98.8

356

62.4

75*

55.3

317

10.1

24.2*

6.4

Cephalosporins 3rd G

Cefodizime

8959

0.4

0.8

0.3

609

1.3

1.3*

1.3

595

2.4

4.2

1.6

320

4.1

3.8

4.1

311

7.7

6.4

8.8

253

8.7

13.5

6.1

269

0.0

0.0

0.0

Ceftazidime

11743

1.2

1.6

1.1

863

5.9

4.8

6.3

776

7.9

12.6*

6.0

487

10.3

12.1

9.6

436

4.1

1.9

6.1

347

13.8

17.6

11.7

310

1.0

1.6

0.8

Ceftibuten

12022

0.9

1.3

0.8

864

3.8

3.9

3.8

791

2.4

1.8

2.6

485

5.8

6.7

5.5

425

26.8

28.2

25.6

355

11.5

15.1*

9.6

313

0.0

0.0

0.0

Cephalosporins 4th

Cefepime

11921

0.3

0.3

0.3

859

3.7

2.4

4.1

763

1.6

2.8

1.1

488

4.1

4.8

3.8

420

4.8

5.0

4.5

349

5.7

8.7*

4.0

314

0.0

0.0

0.0

Monobactams

Aztreonam

11922

2.9

3.5

2.8

861

15.4

14.6

15.7

775

6.2

6.8

5.9

470

21.5

24.2

20.6

423

5.4

5.5

5.4

329

19.8

19.3

20.0

310

5.2

6.3

4.9

Nitrofurans

Nitrofurantoin

11768

6.0

9.0*

5.4

863

95.1

95.7

95.0

768

32.8

39.5*

30.2

483

97.1

100.0*

96.1

—

—

—

—

347

39.5

51.6*

32.6

307

87.3

89.2

86.8

Penicillins

Amoxicillin

11943

42.4

50.3*

40.8

863

47.7

55.3*

45.3

372

96.8

99.0

95.9

487

97.9

99.2

97.5

—

—

—

—

359

98.6

99.2

98.3

314

99.0

100.0

98.8

AMX-CLA

11879

7.5

10.3*

6.9

863

11.8

20.1*

9.2

316

81.6

85.1

80.3

486

32.9

41.9*

29.8

—

—

—

—

345

83.2

87.1

81.0

309

18.4

27.7*

16.0

Piperacillin

11749

19.5

24.0*

18.5

832

20.0

24.7

18.5

—

—

—

—

457

37.4

49.6*

33.4

418

24.2

24.1

24.2

335

34.9

45.8*

29.0

300

26.7

33.8

24.7

Pivmecillinam

11546

15.8

20.9*

14.7

812

37.7

44.7*

35.4

707

24.8

32.4*

21.5

450

59.1

71.9*

54.8

—

—

—

—

323

46.7

57.1*

41.2

285

24.2

32.8*

22.0

Quinolones

Ciprofloxacin

11952

13.9

22.2*

12.2

865

21.3

35.1*

16.9

784

22.3

32.4*

18.3

484

25.0

36.4*

21.2

440

43.4

45.7

41.4

357

23.8

36.9*

16.3

312

18.3

27.7*

15.8

Lomefloxacin

10634

13.7

22.6*

11.9

765

21.8

33.0*

18.5

641

22.9

34.1*

18.8

420

25.2

38.8*

20.8

349

43.8

46.9

41.2

302

25.2

44.7*

15.1

272

18.8

28.3*

16.4

Norfloxacin

11893

14.2

22.8*

12.3

867

22.8

36.2*

18.6

779

21.7

31.3*

18.0

470

24.9

36.2*

21.2

437

44.9

48.1

42.0

355

26.5

44.2*

16.4

307

19.2

29.7*

16.5

Ofloxacin

11937

14.4

23.0*

12.6

860

22.9

35.9*

18.7

783

22.2

32.3*

18.2

483

26.1

38.2*

21.9

438

45.0

48.3

42.1

356

27.2

44.6*

17.3

310

19.4

29.7*

16.7

Sulfonamides

SxT

11907

25.4

33.0*

23.8

831

41.5

55.0*

37.2

776

36.0

41.4

33.8

482

57.3

64.5

54.7

—

—

—

—

356

39.3

56.6*

29.5

303

23.1

30.3

21.1

  1. AMX - CLA Amoxicillin-clavulanic acid, SxT Trimethoprim-Sulfamethoxazole, n total number of bacteria resistant to each antimicrobial, N: total number of bacteria tested against each antimicrobial; — Antimicrobial not tested, M male patient, F female patient, *statistically significant differences (p-value < 0.05) of antimicrobial resistance between female and male patients.
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us